迪奥斯:通过结构和特征综合驱动的方法提高药物向相互作用的预测,并发现潜在的向分子
Yiran Tang1, Shengqiao Gao2, Dan Luo2
1State Key Laboratory of National Security Specially Needed Medicines, Academy of Military Medical Sciences, Beijing 100850, China; Pharmacology of Chinese Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
Pharmacological research
|March 26, 2025
概括
这项研究介绍了DIORS,一种新的方法,集成分子对接和基因签名来预测向药物. 对于Piezo1和TLR4/MD2目标,DIORS成功地确定了潜在的候选药物,证明了其在药物重定位方面的有效性.
科学领域:
- 药理学和生物信息学 药理学和生物信息学
- 计算机化药物发现技术
背景情况:
- 药物向相互作用的预测对于有效的药物开发至关重要.
- 整合结构和转录数据可以改善有效治疗分子的识别.
研究的目的:
- 开发和验证一个集成的计算方法,DIORS,以提高蛋白质向药物预测.
- 评估DIORS在识别具有结合亲和力和治疗活性的分子方面的表现.
主要方法:
- 迪奥斯 (DIORS) 结合了分子对接和基因签名匹配,用于药物重定位.
- 标准Scaler算法被优化,并在DIORS框架内使用.
- 表面等离子体共振 (SPR) 和基于细胞的测试被用于实验验证.
主要成果:
- DIORS预测已知药物与Piezo1具有结合亲和关系,包括gefitinib,rifaximin,bosutinib和vandetanib.
- 对于TLR4/MD2标,DIORS确定了埃诺克索隆,达布拉费尼布和波纳替尼布,它们显示出高结合亲和力和抗炎活性.
- 该方法在预测新型向药物方面表现出很高的性能.
结论:
- 迪奥斯有效地整合了结构和签名信息,以实现更高水平的药物预测.
- 开发的战略加强了对治疗应用的潜在候选药物的识别.
- 迪奥斯代表了一种有前途的方法来加速药物发现和重新定位努力.
关键词:
阿尔特梅瑟 (PubChem CID: 68911) 是一个博苏替尼 (PubChem CID: 5328940) 是一种药物.达布拉费尼布 (PubChem CID: 44462760) 是一种药物.药物重新定位是药物重新定位.药物-标药物相互作用埃诺克索龙 (PubChem CID: 10114) 是一种可以盖菲提尼布 (PubChem CID: 123631) 是一种药物.链接链接链接在LPS (PubChem CID: 155977629) 中使用.脂聚糖类糖化物 脂聚糖类糖化物分子对接是分子对接.这是一个Piezo1.波纳替尼 (PubChem CID: 24826799) 是一种药物.里法西明 (PubChem CID: 6436173) 是一种药物,它可以签名 签名 签名 签名结构 结构 是一个结构.在TLR4/MD2中.范德坦尼布 (PubChem CID: 3081361) 是一个巴西特拉辛 (PubChem CID: 54585) 的使用情况相关概念视频
Structure-Activity Relationships and Drug Design
469
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
469
Drug Discovery: Overview
7.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.3K
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K
Ligand Binding Sites
12.6K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.6K
Drug-Receptor Interactions
4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
Pharmacodynamics: Overview and Principles
921
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
921


